Comprehensive integration of process steps into a miniaturised version of synthetic biology workflows remains a crucial task in automating the design of biosystems. However, each of these process steps has specific demands with respect to the environmental conditions, including in particular the composition of the surrounding fluid, which makes integration cumbersome. As a case in point, transformation, i.e. reprogramming of bacteria by delivering exogenous genetic material (such as DNA) into the cytoplasm, is a key process in molecular engineering and modern biotechnology in general. Transformation is often performed by electroporation, i.e. creating pores in the membrane using electric shocks in a low conductivity environment. However, cell preparation for electroporation can be cumbersome as it requires the exchange of growth medium (high-conductivity) for low-conductivity medium, typically performed via multiple time-intensive centrifugation steps. To simplify and miniaturise this step, we developed an acoustofluidic device capable of trapping the bacterium Escherichia coli non-invasively for subsequent exchange of medium, which is challenging in acoustofluidic devices due to detrimental acoustic streaming effects. With an improved etching process, we were able to produce a thin wall between two microfluidic channels, which, upon excitation, can generate streaming fields that complement the acoustic radiation force and therefore can be utilised for trapping of bacteria. Our novel design robustly traps Escherichia coli at a flow rate of 10 μL min−1 and has a cell recovery performance of 47 ± 3% after washing the trapped cells. To verify that the performance of the medium exchange device is sufficient, we tested the electrocompetence of the recovered cells in a standard transformation procedure and found a transformation efficiency of 8 × 105 CFU per μg of plasmid DNA. Our device is a low-volume alternative to centrifugation-based methods and opens the door for miniaturisation of a plethora of microbiological and molecular engineering protocols.
Pumps are indispensable for analytical applications and ensure controlled fluid movement. Syringe pumps are among today's most prevalent liquid delivery systems, especially for high-pressure, stable, low-flow-rate microfluidic applications. Due to moving mechanical parts of the assembly, regular maintenance is essential to ensure reliable operation and flow rates. However, lubrication of the mechanics is easily overlooked because the research focuses on novel analytical applications rather than on the maintenance of pumps. Here, we investigate the lubrication of the syringe pump guide rods with its effect on the flow rate stability after regular pump cleaning from contaminations. The guide rods of syringe pumps were thoroughly cleaned from any lubricant, and the flow rate for specified flowrates between 5 and 100 μL min−1 was measured, revealing tremendous flow rate fluctuations with a coefficient of variation (CV) value up to 0.34. In contrast, flow rate measurements of syringe pumps with lubricated guide rods show a five-fold smoother flow rate fluctuation depending on the specified flow rate with CV values below 0.07. These differences in flow rate's CV were most significant for pressure drops below 500 mbar, relevant for many lab-on-a-chip applications. In summary, we emphasize the awareness of lubricating moving parts of syringe pumps to achieve constant flow rates, minimize wear, and ensure the reliable operation of, for instance, accurate lab-on-a-chip workflows.
Three different flow control methods are investigated to stop a multilayered flow inside a 3D‐printed microfluidic channel by bringing the average flow velocity from >100 mm s−1 to below a critical velocity of 200 µm s−1 within a certain delay time td of ≈2 s. A sequence of three concentric nozzles is 3D printed (≈75 µm) and embedded serially inside the microchannel (≈200 µm) using a two‐photon polymerization method. The 3D printed device produces a structured coaxial flow of four streams with individual layer thicknesses of O(10 µm). The pressure gradient across the fluidic circuit is removed, from > 2 bar to ≈0 bar, to stop the multilayered flow and measure td to assess the performance of the three stop‐flow methods. During the stop‐flow phase, an inhomogeneous pressure gradient across different inlets resulted in a backflow to inlet channels with lower pressures. The fluidic capacitance is systematically managed to minimize a dimensionless backflow index (BFI) value from ≈0.3 (worst case) to ≈0.03 (best case) for a total flow rate ranging from 16.8 to 168 µL min−1. Finally, the best stop‐flow conditions are recommended, which resulted in a minimal delay time of td ≈ 2 s and a BFI < 0.05.
For the treatment of human immunodeficiency virus (HIV)-infected patients, the regular assessment of the immune status is indispensable. The quantification of CD4+ T lymphocytes in blood by gold standard optical flow cytometry is not point-of-care testing (POCT) compatible. This incompatibility is due to unavoidable pre-analytics, expensive and bulky optics with limited portability, and complex workflow integration. Here, we propose a non-optical, magnetic flow cytometry (MFC) workflow that offers effortless integration opportunities, including minimal user interaction, integrated sample preparation and up-concentration, and miniaturization. Furthermore, we demonstrate immunomagnetic CD4+ T lymphocyte labeling in whole blood with subsequent quantification using sheath-less MFC. Showing linearity over two log scales and being largely unimpaired by hematocrit, evidence is provided for POCT capabilities of HIV patients.
Quantitative cell function measurements are essential for many clinical decisions but are primarily tied to centralized laboratories. Limited access to these laboratories in low-resource settings or for immobile patients highlights the urgent need for Point-of-Care testing (POCT) infrastructure. Magnetic flow cytometers (MFC) offer a solution, albeit phenotyping is limited, and sample processing steps like cell lysis or washing increase MFC's workflow complexity. Here, we investigate conditions for novel phenotyping and direct cell concentration quantification in a streamlined workflow suitable for POCT in high hematocrit environments. We characterize magnetic nanoparticles (MNP) by their size, magnetic moment, and opportunities for high signal-to-noise ratios. With adapted theoretical models, we provide the framework for quantifying bound MNPs per cell. This reveals labeling quality and gives insight into system requirements for reliable cell detection and rational cell phenotyping. We investigate temporal labeling dynamics, which show suboptimal MNP binding kinetics in whole blood (WB), leading to long incubation periods and only 50% recovery concentrations. With our streamlined workflow favoring small (<50 nm) MNPs, we quantify CD14+ monocytes in WB and achieve coefficients of variation of <11%. By simultaneously assessing quantitative epitope expression, we extend MFC's capabilities to clinical subtyping for POCT.
Quantitative cell analysis in liquid biopsies is essential for many clinical decisions, but it is primarily tied to centralized laboratories. However, access to these laboratories is limited in low-resource settings or for immobile patients, highlighting the urgent need for Point-of-Care (POC) testing infrastructure. Magnetic flow cytometers (MFC) offer a solution, albeit sample processing steps like cell lysis or washing crucially disrupt POC-capable MFC workflows. Here, we investigate conditions for immunomagnetic labeling and direct cell quantification in a streamlined workflow suitable for high hematocrit environments. Magnetic nanoparticles (MNP) are characterized by their size, magnetic moment, and potential to generate signal noise, favoring small (< 50 nm) MNPs. Theoretical models provide the framework for quantifying bound MNPs per cell, revealing labeling quality and giving insight into system requirements for reliable cell detection. Temporal labeling dynamics show suboptimal binding kinetics in whole blood (WB), leading to long incubation periods and only 50% recovery of optically determined concentrations. Besides showing quantitative MFC in WB with biomimetic microbeads, we finally quantify CD14 + monocytes in WB with our streamlined workflow, achieving an intra-assay coefficient of variation (CV) of 0.11 and a CV across multiple donors of 0.10, demonstrating reliable POC flow cytometry close to regulatory standards.